Ranzhishou slimming capsules pose a serious risk to your health and should not be taken.
The Therapeutic Goods Administration (TGA) has tested product labelled Ranzhishou slimming capsules and found that:
the capsules contain the undeclared substance sibutramine; and
the capsules contain the undeclared substance phenolphthalein.
Consumers are advised that sibutramine and phenolphthalein are both prescription-only substances in Australia. Sibutramine was withdrawn from world markets in 2010 due to increased risk of cardiac events and stroke, and phenolphthalein was withdrawn from sale on many markets in the late 1990’s due to concerns over its carcinogenicity with long term use.
The supply of Ranzhishou slimming capsules containing sibutramine and phenolphthalein is illegal.
Ranzhishou slimming capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
TGA investigations have shown that a number of people in Australia may have bought the product online.
Information for consumers
Stop taking Ranzhishou slimming capsules and take any remaining capsules to your local pharmacy for safe disposal.
If you have any concerns arising from your use of this product, consult your health care practitioner.
Action the TGA is taking
The TGA is working with the Australian Border Force (ABF) to help stop future shipments of Ranzhishou slimming capsules from entering Australia.
If these capsules are found at the border by the ABF they will be seized and destroyed.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.